Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

CGN.c (CANADA); CGNSF (USA); 1UB (GERMANY)

Discussion in 'Penny Stocks' started by SwedeProf, Mar 13, 2019.

  1. SwedeProf

    SwedeProf New Member

    Joined:
    Mar 13, 2019
    Messages:
    10
    Likes Received:
    0
    Cognetivity is a medical software application used to help detect and diagnose Dementia and Alzheimer's in patients early.

    This news today is a big deal, receiving this ISO certification! It is required for a medical device approval with Health Canada, NHS, and other governing bodies in Europe and Australia etc (FDA doesn’t require this cerification).

    They are in the middle of their final study (a third party clinical validation study) which will be completed shortly, and with this ISO 13485 certification will allow them approval from many countries such as Canada, USA, Australia, and the E.U.

    Many near to mid term catalysts and major coverage from many investment publications, such as Fobes, Bloomberg, Globe & Mail, and others. (I’ll post links in comments)

    Low market cap $12mil USD. Very tight share structure.

    I’ll continue my DD on this thread. Comments and other DD are certainly welcomed!


    https://www.newswire.ca/news-releas...Xsy9COmFqkldqbLfXtif-1-aKiv9IAXfloP4s-ilpSFBY
     
  2. SwedeProf

    SwedeProf New Member

    Joined:
    Mar 13, 2019
    Messages:
    10
    Likes Received:
    0
    Ok, so as Tom mentioned in this video ( ) there are potential revenue streams. I’ve been told we can expect these revs in Q2 (I believe their Fiscal YE is Jan 31 so Q2 is only weeks away) I believe we see revenues from 2 sources…. First is from the Dacadoo partnership they signed in Nov 2018 http://www.newswire.ca/en/releases/archive/November2018/06/c1814.html

    Dacadoo has partnerships with major insurance companies who White Label Dacadoo’s backend software. The platform calculates a real-time Health Score for each user based on 3 key areas: Lifestyle (exercise, nutrition, stress and sleep), Body (biometric measures), and Mind (mental well-being), and motivates users through automated lifestyle coaching, gamification, social features and a reward system. So as a insurance policy holder eats better, sleeps better, exercises more often, takes methods to increase mental health (this is how Cognetivity fits in), they are rewarded with cheaper insurance premiums and the insurance company saves millions of dollars… and Cognetivity will receive a subscription fee from each of these insurance companies!

    The second potential revenue stream is from the partnership they signed in Jan 2019 with Dementias Platform UK.I believe how this partnership works is the first chunk of revenue (still DDing how much) is given back to DPUK and after that Cognetivity retains full revenues.
    https://www.cognetivity.com/dpuk-partner-announcement-cognetivity/

    I’m really looking forward to Q2 as I believe this will be the start of many catalysts:
    1. Revenues
    2. Validation study completed
    3. FDA application approval with 3 months of successful validation study
     
  3. SwedeProf

    SwedeProf New Member

    Joined:
    Mar 13, 2019
    Messages:
    10
    Likes Received:
    0
    CGN.c NEWS.

    http://www.newswire.ca/en/releases/archive/March2019/27/c6782.html


    This is an incredible news release that explains how Cognetivity’s ‘Integrated Cogenitive Assessment’ (ICA) works and correlates to the huge advances in blood plasma neurofilament light (NfL). If you don’t know what NfL is here are a couple links to get your started.

    https://milbankmonitor.com/medical-...rain-damage-years-before-symptoms/17/03/2019/

    https://alzres.biomedcentral.com/articles/10.1186/s13195-018-0404-9


    NfL is a blood test that has been used successfully to detect M.S. And recently has been proven to detect brain damage and mental health issues such as Dementia and Alzheimers long before the traditional methods of detection could do so. Cogentivity’s ICA results have a 0.79 correlation to the results of NfL tested patients. This is BIG NEWS! Patients will no longer have to do an invasive test that takes days/weeks to get results back from a lab. They could now do Cognetivity’s 5 min test while waiting to see their GP/Doctor. Once uploaded to the Cloud the doctor can then review results, and if there are any signs or issues with the test results, at that point the doctor can refer the patient for an NfL test to confirm if there is a mental health issue like Dementia or Alzheimer’s.

    This is also important for pharmaceutical companies running drug tests on candidates to see if the drug being administered can reverse or stop the symptoms of Alzheimer’s/Dementia/etc. Drug companies have to prove their drug does what they claim and these cognitive assessments (similar to CGN’s ICA) are one of the ways they do that. From my understanding the best correlation out there from other cognitive assessment tests is 0.39; and now CGN’s assessment has a independent study verifying a 0.79 correlation to the NfL test (That’s 2X better than any other assessment)


    IMO this is MASSIVE news and another validation of their technology. No wonder Insurance companies are wanting to use this.

    http://www.newswire.ca/en/releases/archive/March2019/27/c6782.html
     
  4. SwedeProf

    SwedeProf New Member

    Joined:
    Mar 13, 2019
    Messages:
    10
    Likes Received:
    0
    This got me pretty excited! Everyone looks for a mentor that they can look to, to replicate for success. These screenshots show that both Baron Group and Rockshield Capital know how to spot success. My favourite, and the one I believe will be the next big winner for both of these investment groups is Cogentivity (CSE:CGN). I’ve been posting a lot about them over the last weeks, insiders hold a heavy position and the company has been hitting many milestones. If you want a proven system look at these success stories from their sites and some info I’ve gathered below.

    - Baron helped take iAnthus Capital holdings public by working with the exchange to get them listed. They’ve participated in financings when the company had a market cap of $23.6Mil and now it is valued at $389Mil (1.40/share and now trading at 7.43/share). They also participate in ongoing pub. Co. management.

    - Baron Group also took Novo Resources public in an IPO. They have participated in financings and have helped grow the company to a market cap of $476Mil.

    - Baron Group has been involved with Helius since day one - took Helius public through a reverse take over and have been involved in capital raises and apart of pub co management. Started them at .50c and now trading over $9.00 and a market cap of about 250mil! Rockshield has also been involved in Helius.

    - Rockshield helped with investment and raises in Green Organic Dutchman. TGOD now trades with a $1.3Billion market cap.

    The connection between these two investment groups is that they both financially backed many MANY successful companies, proving these groups can spot and know what success looks like! And they are BOTH backing Cognetivity (CSE:CGN).

    https://barongroupintl.com/clients.html

    https://www.rockshield.ca/#section-clients
     

Share This Page